Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue BMC Infectious Diseases Année : 2016

Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens

Résumé

Rapid diagnostic tests (RDTs) have been commercialized in order to help physicians in dengue diagnosis. Until recently, only blood samples were used for those tests but it has been shown in several studies that urine and saliva can also be employed for dengue diagnosis. RDTs for the detection of NS1 antigen and anti-dengue IgG, IgM and IgA in urine and saliva specimens have thus been developed by Standard Diagnostics. The aim of this study was to evaluate the performances these new commercial assays.
Fichier principal
Vignette du fichier
Andries_2016_BMC_infect_dis.pdf (463.13 Ko) Télécharger le fichier
Loading...

Dates et versions

pasteur-02003956 , version 1 (01-02-2019)

Licence

Paternité

Identifiants

Citer

Anne-Claire Andries, Veasna Duong, Sivuth Ong, Sopheaktra Ros, Anavaj Sakuntabhai, et al.. Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens. BMC Infectious Diseases, 2016, 16 (1), pp.201. ⟨10.1186/s12879-016-1551-x⟩. ⟨pasteur-02003956⟩
68 Consultations
202 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More